Mukka Proteins Limited has informed the Exchange about Acquisition
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins' board has approved acquiring an additional 25.99% stake (1,000 equity shares) in its subsidiary Ento Proteins Private Limited (EPPL) for Rs. 32.30 lakh in cash. Post-acquisition, EPPL will become a wholly owned subsidiary of Mukka Proteins, up from the current 74.01% holding. EPPL manufactures insect meal and insect oil and reported a turnover of Rs. 7.46 crore and profit after tax of Rs. 49.47 lakh in FY25. The deal is part of Mukka Proteins' strategy to expand its alternate proteins business and is expected to be completed by 30 June 2026. The transaction is with a related party but has been done at arm's length.
This is a small, incremental acquisition (Rs. 32.30 lakh) to consolidate full ownership of an existing subsidiary in the alternate proteins segment, so the direct financial impact is minor. However, it signals Mukka Proteins' strategic commitment to the insect protein business, which could matter for long-term growth if the segment scales up.